Novel targets against Helicobacter pylori: A bioinformatic approach

Future Microbiology

Volumn 2, Issue 2, 2007, Pages 111-114

  Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bioinformatics; Drug resistance; Helicobacter pylori; XGPRTase; XGPRTase inhibitors

Indexed keywords

ALPHA CARBONATE DEHYDRATASE; AMOXICILLIN; BISMUTH; CARBONATE DEHYDRATASE; CLARITHROMYCIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METRONIDAZOLE; PROTON PUMP INHIBITOR; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; BINDING AFFINITY; BIOINFORMATICS; CHRONIC GASTRITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG TARGETING; DRUG TREATMENT FAILURE; ENZYME PURIFICATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; PHYLOGENY; PRIORITY JOURNAL; PURINE SYNTHESIS; PYRIMIDINE SYNTHESIS; REVIEW; SEQUENCE ALIGNMENT; STOMACH CANCER; STOMACH PH; SYSTEMATIC REVIEW; THEORETICAL MODEL; UNSPECIFIED SIDE EFFECT;

EUKARYOTA; HELICOBACTER PYLORI;

EID: 34248671094     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.2.111     Document Type: Review

References (20)

1. Duckworth M, Menard A, Megraud F, Mendz GL: Bioinformatic analysis of Helicobacter pylori XGPRTase: a potential therapeutic target. Helicobacter 11, 287-295 (2006).
2. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 16, 1311-1315 (1984).
3. Suerbaum S, Michetti P: Helicobacter pylori infection. N. Engl. J. Med. 347, 1175-1186 (2002).
4. Malfertheiner P, Megraud F, O'Morain C et al.: European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16, 167-180 (2002).
5. Lam SK, Talley NJ: Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J. Gastroenterol. Hepatol. 13, 1-12 (1998).
6. Huang JQ, Hunt RH: Treatment after failure: the problem of 'non-responders'. Gut 45(Suppl. 1), I40-I44 (1999).
7. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL: Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment. Pharmacol. Ther. 13, 857-864 (1999).
8. Fischbach LA, van Zanten S, Dickason J: Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti- Helicobacter pylori quadruple therapies. Aliment. Pharmacol. Ther. 20, 1071-1082 (2004).
9. Gisbert JP, Pajares JM: Helicobacter pylori therapy: first-line options and rescue regimen. Dig. Dis. 19, 134-143 (2001).
10. Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ: Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment. Pharmacol. Ther. 18, 347-353 (2003).
11. Lamouliatte H, Megraud F, Delchier JC: Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies. Aliment. Pharmacol. Ther. 18, 791-797 (2003).
12. Mantzaris GJ, Petraki K, Archavlis E et al.: Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. Eur. J. Gastroenterol. Hepatol. 14, 1237-1243 (2002).
13. Sachs G, Weeks DL, Wen Y, Marcus EA, Scott DR, Melchers K: Acid acclimation by Helicobacter pylori. Physiology (Bethesda) 20, 429-438 (2005).
14. Tomb JF, White O, Kerlavage AR et al.: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539-547 (1997).
15. Nishimori I, Minakuchi T, Morimoto K et al.: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J. Med. Chem. 49, 2117-2126 (2006).
16. Nishimori I, Vullo D, Minakuchi T et al.: Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. Bioorg. Med. Chem. Lett. 16, 2182-2188 (2006).
17. Marcus EA, Moshfegh AP, Sachs G, Scott DR: The periplasmic α-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J. Bacteriol. 187, 729-738 (2005).
18. Supuran CT, Scozzafava A, Casini A: Carbonic anhydrase inhibitors. Med. Res. Rev. 23, 146-189 (2003).
19. Mendz GL, Shepley AJ, Hazell SL, Smith MA: Purine metabolism and the microaerophily of Helicobacter pylori. Arch. Microbiol. 168, 448-456 (1997).
20. Mendz GL, Jimenez BM, Hazell SL, Gero AM, O'Sullivan WJ: Salvage synthesis of purine nucleotides by Helicobacter pylori. J. Appl. Bacteriol. 77, 674-681 (1994).